Quanterix Corporation to Release Fourth Quarter and Fiscal 2021 Financial Results on March 1, 2022
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing precision health science, today announced that it will report financial results for the fourth quarter of 2021 before the start of the trading on Tuesday, March 1, 2022. will host a conference call at 8:30 a.m. EST to discuss Quanterix’s financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, President and CEO of Quanterix.
Those interested in listening to the conference call can do so by dialing (833) 686-9351 for domestic callers or (612) 979-9890 for international callers. Please refer to the following conference ID: 5230769. A live webcast will also be available at: https://edge.media-server.com/mmc/p/udpgv5ou. You can also access the live webcast by visiting the News and Events page of the Investors section of the Quanterix site at www.quanterix.com. The webcast will be available on the Company’s website for one year after the call ends.
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way healthcare is delivered today by giving researchers the ability to look closely at the health-to-illness continuum. Quanterix’s technology is designed to enable much earlier disease detection, better prognoses, and improved treatment methods to improve people’s quality of life and longevity for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For more information, please visit https://www.quanterix.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.” and similar expressions (as well as other words or expressions that refer to future events, conditions or circumstances) are intended to identify the forward-looking statements. The forward-looking statements contained in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that could cause a difference between Quanterix’s actual results and those expressed or implied by the forward-looking statements in this press release are discussed in Quanterix’s filings with the United States Securities and Exchange Commission, including the “Factors in Risk” contained herein. Except as required by law, Quanterix assumes no obligation gation to update the forward-looking statements contained herein to reflect any changes in expectations, even when new information becomes available.